Study Phase II Flexitheralight

The Phase II study evaluating the non-inferiority of the Flexitheralight device compared to conventional phototherapy (PDT), whose investigator-coordinator is Prof. Laurent MORTIER - Department of Dermatology - CHRU of LILLE received a favorable opinion of the ANSM (Registration No. 2013-A01096-39), on 27 November 2013.

The purpose of this study is to validate the Flexitheralight device developed jointly by INSERM U703 (Dir: Serge MORDON) and ENSAIT (Dir: Vladan KONCAR).

This study is financed by the ANR Emergence 2012 program (Project reference: ANR-12-EMMA-0018)